相关实验视频

Updated: Jun 30, 2025

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer

Published on: January 17, 2025

在晚期胰腺癌中使用的林塔托利莫德可以通过树突细胞介导的T细胞反应增强抗瘤免疫力

Casper W F van Eijck^1,2, Hassana El Haddaoui¹, Songul Kucukcelebi^1,2

¹Department of Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands.

Clinical cancer research : an official journal of the American Association for Cancer Research

|March 15, 2024

概括

林塔托利莫德是一种托尔类受体3 (TLR-3) 激动剂,通过增强树突细胞和T细胞活性来提高晚期胰腺癌的抗瘤免疫力. 这种免疫刺激可能会改善患者的生存率,并为组合疗法提供潜力.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
药理学药理学是指药理学的学科.

背景情况:

胰腺管腺癌 (PDAC) 的生存率很低,需要新的治疗策略.
基于免疫的疗法正在成为癌症治疗的有希望的途径.
林塔托利莫德是一种托尔类受体3 (TLR-3) 激动剂,具有直接抗PDAC作用和免疫系统调节的潜力.

研究的目的:

为了研究由rintatolimod激活TLR-3对晚期PDAC患者的周围免疫系统的影响.
评估林塔利莫德如何影响免疫细胞种群及其激活标记物.

主要方法:

在基线和经过rintatolimod治疗后,对30名晚期PDAC患者的配对血液样本进行分析.
免疫细胞的综合性转录组 (纳米链) 和蛋白组 (流细胞计) 分析.
单变Cox比例危险模型来评估免疫因素与生存之间的相关性.

主要成果:

林塔托利莫德治疗在转录和蛋白质层面显著增强了周围免疫活性.
增加1型常规树突细胞 (cDC1) 和T细胞的丰度,特别是BTLA+ XCR1+ cDC1s和CD4+ SELL+ T细胞,与改善的结果相关.
患有稳定疾病的患者表现出DC和T细胞激活基因的表达增加,而患有进展性疾病的患者表现出IDO1和PD-1的表达增加.

结论:

通过rintatolimod激活TLR-3显示出免疫刺激性质,可能克服PDAC的免疫耐受性.
林塔托利莫德通过树突细胞介导的T-辅助细胞反应增强抗瘤免疫力.
这些发现支持进一步研究将TLR-3激活与免疫检查点抑制剂结合起来,以改善PDAC治疗结果.

更多相关视频

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...